Nevisense is a non-invasive tool for monitoring skin barrier function with several applications in beauty, cosmetics, and personal care. It’s advanced Electrical Impedance Spectroscopy (EIS) is emerging as a powerful technique for evaluating skin barrier function with high sensitivity and reproducibility. Nevisense has been featured in over 85 studies to date, providing quantitative insights into hydration status, inflammation, and stratum cormeum integrity.
The EIS technology goes beyond traditional methods of skin barrier analysis by capturing features of tissue health and cellular changes. Methods such as transepidermal water loss (TEWL) remain widely used, but their results are influenced by external factors such as ambient humidity, temperature, or caffeine intake. EIS measures the skin’s electrical impedance, offering a more robust assessment of barrier function. Recent comparative studies (e.g. Huygen et al., 2024) have shown greater sensitivity of EIS in detecting subtle physiological changes both in vitro and in vivo compared to TEWL.
Applications of EIS extend beyond basic skin hydration analysis. Nevisense has been employed to monitor inflammatory changes, UVB-induced damage, and oxidative stress effects on the barrier (Hernandez et al., 2019; Rinaldi et al., 2023). It also supports longitudinal tracking of skin responses to topical treatments, providing objective data on efficacy (Yayci et al., 2024).
With the cosmetic industry pushing for more robust and evidence-based testing methods, EIS is increasingly incorporated into product evaluation as a trusted tool for skin analysis. Nevisense offers a non-invasive, sensitive, and quantifiable means of assessing skin physiology, enabling researchers to track subtle changes and treatment effects with greater accuracy. As the field continues to evolve, EIS is emerging as a cornerstone of skincare research with its potential to enhance product development and improve patient outcomes.
CONTACT
Discover their latest services during the exclusive webinar and the latest evaluation trends and innovations in preclinical trials and clinical studies.
